Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Guillermet-Guibert J et al. | Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. | 2009 | Mol. Cancer Ther. | pmid:19372554 |
Dindo D et al. | Cationic long-chain ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells. | 2006 | Mol. Cancer Ther. | pmid:16818511 |
Gstalder C et al. | FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model. | 2016 | Mol. Cancer Ther. | pmid:27507852 |
Brizuela L et al. | First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. | 2012 | Mol. Cancer Ther. | pmid:22784711 |
Wang D et al. | S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells. | 2008 | Mol. Cancer Ther. | pmid:18645009 |
Min J et al. | (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. | 2007 | Mol. Cancer Res. | pmid:17699106 |
Young N et al. | Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. | 2009 | Mol. Cancer Res. | pmid:19147534 |
Li MH et al. | Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. | 2008 | Mol. Cancer Res. | pmid:18922980 |
Schneider G et al. | Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy. | 2013 | Mol. Cancer Res. | pmid:23615526 |
Langlois S et al. | Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation. | 2007 | Mol. Cancer Res. | pmid:17541067 |
Bryan L et al. | Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. | 2008 | Mol. Cancer Res. | pmid:18819934 |
Schnitzer SE et al. | Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. | 2009 | Mol. Cancer Res. | pmid:19240180 |
Fisher KE et al. | Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. | 2006 | Mol. Cancer | pmid:17156449 |
Hu PF et al. | Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis. | 2011 | Mol. Biol. Rep. | pmid:21116853 |
Liu CH et al. | Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. | 1999 | Mol. Biol. Cell | pmid:10198065 |
Weis N et al. | Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. | 2009 | Mol. Biol. Cell | pmid:19129475 |
Malchinkhuu E et al. | Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cells. | 2009 | Mol. Biol. Cell | pmid:19864456 |
Reinhard NR et al. | The balance between Gα-Cdc42/Rac and Gα/-RhoA pathways determines endothelial barrier regulation by sphingosine-1-phosphate. | 2017 | Mol. Biol. Cell | pmid:28954861 |
Dudek SM et al. | Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. | 2010 | Mol. Biol. Cell | pmid:20861316 |
Yamamoto S et al. | A role of the sphingosine-1-phosphate (S1P)-S1P receptor 2 pathway in epithelial defense against cancer (EDAC). | 2016 | Mol. Biol. Cell | pmid:26631556 |
Weigert A et al. | Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate. | 2007 | Mol. Biol. Cell | pmid:17652460 |
Squecco R et al. | Sphingosine 1-phosphate induces myoblast differentiation through Cx43 protein expression: a role for a gap junction-dependent and -independent function. | 2006 | Mol. Biol. Cell | pmid:16957055 |
Deretic D et al. | Phosphoinositides, ezrin/moesin, and rac1 regulate fusion of rhodopsin transport carriers in retinal photoreceptors. | 2004 | Mol. Biol. Cell | pmid:13679519 |
Wirotanseng LN et al. | Gq rather than G11 preferentially mediates nociceptor sensitization. | 2013 | Mol Pain | pmid:24156378 |
Langeslag M et al. | Sphingosine 1-phosphate to p38 signaling via S1P1 receptor and Gαi/o evokes augmentation of capsaicin-induced ionic currents in mouse sensory neurons. | 2014 | Mol Pain | pmid:25431213 |
Tsai CH et al. | Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression. | 2017 | Mol Oncol | pmid:28672103 |
Brizuela L et al. | Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells. | 2014 | Mol Oncol | pmid:24768038 |
Riley RT et al. | Evidence for fumonisin inhibition of ceramide synthase in humans consuming maize-based foods and living in high exposure communities in Guatemala. | 2015 | Mol Nutr Food Res | pmid:26264677 |
Sanagawa A et al. | Sphingosine 1‑phosphate induced by hypoxia increases the expression of PAI‑1 in HepG2 cells via HIF‑1α. | 2016 | Mol Med Rep | pmid:27357063 |
Moon MH et al. | Activation of S1P2 receptor, a possible mechanism of inhibition of adipogenic differentiation by sphingosine 1‑phosphate. | 2015 | Mol Med Rep | pmid:25351259 |
Jeong JK et al. | Modulation of the expression of sphingosine 1-phosphate 2 receptors regulates the differentiation of pre-adipocytes. | 2015 | Mol Med Rep | pmid:26459774 |
Garnero P | The Utility of Biomarkers in Osteoporosis Management. | 2017 | Mol Diagn Ther | pmid:28271451 |
Van Brocklyn JR | Sphingolipid signaling pathways as potential therapeutic targets in gliomas. | 2007 | Mini Rev Med Chem | pmid:17979800 |
Banitalebi E et al. | The effect of resistance training on plasma S1P level and gene expression of S1P1,2,3 receptors in male Wistar rats. | 2013 | Minerva Endocrinol. | pmid:24285107 |
Wang L and Dudek SM | Regulation of vascular permeability by sphingosine 1-phosphate. | 2009 | Microvasc. Res. | pmid:18973762 |
Sun X et al. | Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement. | 2009 | Microvasc. Res. | pmid:19323978 |
Brown M et al. | Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium. | 2010 | Microvasc. Res. | pmid:20053363 |
Wang L et al. | Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonate. | 2015 | Microvasc. Res. | pmid:25862132 |
Belvitch P and Dudek SM | Role of FAK in S1P-regulated endothelial permeability. | 2012 | Microvasc. Res. | pmid:21925517 |
Tachikawa M et al. | Lysophospholipids enhance taurine release from rat retinal vascular endothelial cells under hypoosmotic stress. | 2009 | Microvasc. Res. | pmid:19804786 |
Belvitch P et al. | Proline-rich region of non-muscle myosin light chain kinase modulates kinase activity and endothelial cytoskeletal dynamics. | 2014 | Microvasc. Res. | pmid:25072537 |
Garcia JG | Concepts in microvascular endothelial barrier regulation in health and disease. | 2009 | Microvasc. Res. | pmid:19232241 |
Kimizuka K et al. | Sphingosine 1-phosphate (S1P) induces S1P2 receptor-dependent tonic contraction in murine iliac lymph vessels. | 2013 | Microcirculation | pmid:22913344 |
Schulz C et al. | Trafficking of murine hematopoietic stem and progenitor cells in health and vascular disease. | 2009 | Microcirculation | pmid:19479622 |
Zhang L et al. | Sphingosine-1-phosphate Maintains Normal Vascular Permeability by Preserving Endothelial Surface Glycocalyx in Intact Microvessels. | 2016 | Microcirculation | pmid:27015105 |
Markiewicz M et al. | Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. | 2011 | Microcirculation | pmid:21166920 |
McQuiston T et al. | Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. | 2011 | Microbiology (Reading, Engl.) | pmid:21292747 |
Azimzadeh K et al. | Evaluation of plasma sphingosine 1-phosphate, hepcidin and cardiovascular damage biomarkers (cardiac troponin I and homocysteine) in rats infected with brucellosis and vaccinated (Rev-1, RB-51). | 2017 | Microb. Pathog. | pmid:28533142 |
Lavieu G et al. | Sphingolipids in macroautophagy. | 2008 | Methods Mol. Biol. | pmid:18425450 |
Woszczek G and Fuerst E | Ca2+ mobilization assays in GPCR drug discovery. | 2015 | Methods Mol. Biol. | pmid:25563178 |